Latest News about GSK
Recent news which mentions GSK
3 Deeply Undervalued Growth Stocks
October 27, 2023
From InvestorPlace
Bank Of America, Mastercard, NRA And Others Are Lobbying For Cannabis Banking Reform — Who Knew?
October 22, 2023
From Benzinga
Pfizer gets FDA green light for new shot that can streamline teenagers’ vaccinations
October 20, 2023
From MarketWatch
Startup Cerebras stands out in the high-risk AI chip arena: ‘No one has built a chip this big’
October 11, 2023
From MarketWatch
From Benzinga
China-Based Zhifei Biological Partners With GSK To Expand Shingrix Vaccine Access Across China Via £2.5B Deal
October 09, 2023
Tickers
GSK
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
7 ‘Smart Money’ Stocks Set to Explode Higher
September 30, 2023
From InvestorPlace
Moderna's Shares Could Take Off if These 2 Things Happen
September 30, 2023
From Motley Fool
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
September 27, 2023
From Benzinga
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
September 26, 2023
From Benzinga
Why Are Antifungal Focused Scynexis Stock Plunging Today?
September 25, 2023
From Benzinga
CDC Backs Pfizer's RSV Infection Maternal Vaccine During Pregnancy As Protection For Infants
September 25, 2023
From Benzinga
From Benzinga
European Commission Approves GSK/Pfizer-Backed HIV Infection Prevention Drug
September 19, 2023
From Benzinga
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
September 18, 2023
From Benzinga
One Year Into Kabir Nath's Leadership, Compass Pathways' (NASDAQ: CMPS) Phase 3 Trial For Innovative Treatment Resistant Depression Progressing
September 18, 2023
From Benzinga
Pleasant Surprise For GSK: FDA Approves Bone Marrow Cancer Therapy Acquired Via Sierra Oncology Deal
September 18, 2023
Tickers
GSK
From Benzinga
Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs
September 14, 2023
From Benzinga
Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm
September 13, 2023
From InvestorPlace
Moderna aims to prove it’s ‘more than a COVID company’
September 13, 2023
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.